Life after Levaquin samples????

[Anonymous]

I am on fumes with Levaquin samples! My trunk is almost empty! Without samples my access goes down 70%. Bring on Riva!

 

[Anonymous]

pharma gig..... OVER

 

[Anonymous]

pharma gig..... OVER

The pain sales force has done a pretty good job without samples. It's ok AI/GI, doctors are really ok with real world conversations that are meant to help the patient and their practice. I never understood the reason why we gave away scripts of a life-saving drug anyway. Levaquin was well covered and affordable for most patients. Nucynta...that's another story.

 

[Anonymous]

You are all screwed. The writing has been on the wall for years. You should have figured out an exit strategy a long time ago. Good luck.

 

[Anonymous]

I am on fumes with Levaquin samples! My trunk is almost empty! Without samples my access goes down 70%. Bring on Riva!

You should be embarrassed.

 

[Anonymous]

I am on fumes with Levaquin samples! My trunk is almost empty! Without samples my access goes down 70%. Bring on Riva!

If you need samples to sell, then I hope you are not around when we launch Rivaroxaban. On the hospital side, we actually have to sell. You are a caterer/UPS driver. Good Luck.

 

[Anonymous]

It's a big loss that we won't have samples anymore. In-services and samples are the only reason that most physicians still allow reps through the doors. The industry is realizing that taking away samples as well as detail people from the field does not impact sales and is a huge cost savings. In fact Astra Zeneca recently eliminated the entire salesforce promoting Nexium as well as all product sampling and instead opened the Nexium Call Center where physicians could order samples of Nexium on line and speak to Trained Customer Service Representatives to receive product information. Astra Zeneca actually reported increased Nexium sales profits without field sales reps. Many pharmaceutical companies are moving in this direction since access is so limited with physicians and costs are so low with Customer Service Centers and direct sample and product information shipments.

 

[Anonymous]

Burt Reynolds is a legend

 

[Anonymous]

It's a big loss that we won't have samples anymore. In-services and samples are the only reason that most physicians still allow reps through the doors. The industry is realizing that taking away samples as well as detail people from the field does not impact sales and is a huge cost savings. In fact Astra Zeneca recently eliminated the entire salesforce promoting Nexium as well as all product sampling and instead opened the Nexium Call Center where physicians could order samples of Nexium on line and speak to Trained Customer Service Representatives to receive product information. Astra Zeneca actually reported increased Nexium sales profits without field sales reps. Many pharmaceutical companies are moving in this direction since access is so limited with physicians and costs are so low with Customer Service Centers and direct sample and product information shipments.

Look around. Nexium reps are back. This time it's through a contract sales force. The profits from their call center vs. reps may have gone down.

 

[Anonymous]

Proud to be a Quintiles rep and happy to be working on contract for jnj! If you are impressed with your cso counterparts and how hard we work out there for much less, please tell your managers so we can apply to jnj when our contracts are up. Thanks!

 

[Anonymous]

It's a big loss that we won't have samples anymore. In-services and samples are the only reason that most physicians still allow reps through the doors. The industry is realizing that taking away samples as well as detail people from the field does not impact sales and is a huge cost savings. In fact Astra Zeneca recently eliminated the entire salesforce promoting Nexium as well as all product sampling and instead opened the Nexium Call Center where physicians could order samples of Nexium on line and speak to Trained Customer Service Representatives to receive product information. Astra Zeneca actually reported increased Nexium sales profits without field sales reps. Many pharmaceutical companies are moving in this direction since access is so limited with physicians and costs are so low with Customer Service Centers and direct sample and product information shipments.

Nexium is being represented by contract reps indeed!, and remember that Nexium is an old established drug, and prescribers require very little education on it (none!). More complex medications and many new medications need a rep to deliver the message.

 

[Anonymous]

Or better yet, a qualified non-sales Pharm D working at the company customer service call center who can give the customers all the updated and clinical information they are really looking for. Nurses and doctors want more than the highlights of the detail piece and a 20-year old package insert, which are the only things reps are allowed to talk about and use anymore.

 

[Anonymous]

It's a big loss that we won't have samples anymore. In-services and samples are the only reason that most physicians still allow reps through the doors. The industry is realizing that taking away samples as well as detail people from the field does not impact sales and is a huge cost savings. In fact Astra Zeneca recently eliminated the entire salesforce promoting Nexium as well as all product sampling and instead opened the Nexium Call Center where physicians could order samples of Nexium on line and speak to Trained Customer Service Representatives to receive product information. Astra Zeneca actually reported increased Nexium sales profits without field sales reps. Many pharmaceutical companies are moving in this direction since access is so limited with physicians and costs are so low with Customer Service Centers and direct sample and product information shipments.

You don't bring any value (other than samples and sandwiches) because you don't need a sales force to sell a 10 year old commodity product that everyone knows how to use. WTF. Duh?

 

[Anonymous]

It's a big loss that we won't have samples anymore. In-services and samples are the only reason that most physicians still allow reps through the doors. The industry is realizing that taking away samples as well as detail people from the field does not impact sales and is a huge cost savings. In fact Astra Zeneca recently eliminated the entire salesforce promoting Nexium as well as all product sampling and instead opened the Nexium Call Center where physicians could order samples of Nexium on line and speak to Trained Customer Service Representatives to receive product information. Astra Zeneca actually reported increased Nexium sales profits without field sales reps. Many pharmaceutical companies are moving in this direction since access is so limited with physicians and costs are so low with Customer Service Centers and direct sample and product information shipments.

J&J already has call centers. Also, here's a quote from a 2009 BusinessWeek column that has NEVER BEEN DISAVOWED by J&J Executives:

"J&J is also looking at streamlining its sales organization—a process that may involve replacing salespeople with technology. Some products, such as drugs that are sold to primary-care physicians, might not need to be marketed by high-priced sales reps. Instead the company can direct the doctors to interactive Web sites and other informational resources. J&J might be better served, McCoy says, by using sales reps to call on specialists, who prescribe complicated products that really require one-on-one explanations. "In the past, we would be going and detailing products to primary-care physicians," McCoy said in September. "Now we're taking sales forces out, and the way we interact with those physicians is directly through the Web site.""
http://www.businessweek.com/bwdaily/dnflash/content/nov2009/db2009113_481501.htm

While I'm at it, look up the thread on Riva. The data suggest Riva will have to be narrowly focused, not shotgunned to the entire PC market. If that's the case, I predict PC will NEVER SELL IT.

2009 redux. It was 1000 people cut then. Exactly how many are left in Pricara these days?

 

[Anonymous]

The only time a specialist or his office might be somewhat interested in meeting with a detail person is right after the launch of a brand-new drug in order to answer any questions. This almost always involves a question that the reps aren't authorized to discuss because it usually deals with reimbursement or information not within the package insert. The detail person then fills out the necessary request authorization forms for additional information and faxes the form to the reimbursement or clinical department. This could easily handled by eliminating drug reps, increasing direct product information to medical professionals and their office managers, expanding reimbursement and clinical call centers with qualified professionals, as well as provide customers with the direct contact information for clinical PharmD Representatives and Reimbursement Specialists in the area who the medical professionals could contact directly and attain the exact information they are seeking immediately without waiting a week for the sales rep to fax the paperwork into the home office. This would instantaneous increase product sales without the cost of field personnel. It doesn't matter if it's primary care or specialty products. Detail people and their managers are unnecessary middle-men and will be eliminated in the near future.

 

[Anonymous]

The only time a specialist or his office might be somewhat interested in meeting with a detail person is right after the launch of a brand-new drug in order to answer any questions. This almost always involves a question that the reps aren't authorized to discuss because it usually deals with reimbursement or information not within the package insert. The detail person then fills out the necessary request authorization forms for additional information and faxes the form to the reimbursement or clinical department. This could easily handled by eliminating drug reps, increasing direct product information to medical professionals and their office managers, expanding reimbursement and clinical call centers with qualified professionals, as well as provide customers with the direct contact information for clinical PharmD Representatives and Reimbursement Specialists in the area who the medical professionals could contact directly and attain the exact information they are seeking immediately without waiting a week for the sales rep to fax the paperwork into the home office. This would instantaneous increase product sales without the cost of field personnel. It doesn't matter if it's primary care or specialty products. Detail people and their managers are unnecessary middle-men and will be eliminated in the near future.

You are half right. Middle managers are completely unnecessary. Whenever weeklies are tracked, many drugs that do not sell themselves, end up going down during meeting/holiday breaks. That is why many of us still have jobs.